Tag Cloud

What is a tag cloud?

Current tags: Clear current tags
View full tag cloud
Advertisement
Q

At what level of cholesterol would you consider testing for familial hypercholesterolaemia and what tests should be done?

Associated tags: Cardiovascular disease, cholesterol, familial hyperlipidaemia

Question DetailsView Comments (0)
A

ANSWER

provided by Trip / NLH
Search
Moderate
Appraisal
Moderate
Confidence
Good

Answer Rating key

search strong
appraisal weak
confidence moderate

Question answered:11/10/07 Warning! this question is over two years old.

The CKS guideline on cardiovascular risk [1] states:

 

“Familial combined hyperlipidaemia is a genetic disease in which members of a family have hypercholesterolaemia and hypertriglyceridaemia. The pattern of inheritance is complex. Individuals may have either hypercholesterolaemia, or hyperlipidaemia, or both, or neither — hyperlipidaemia usually does not appear in affected individuals before middle age. All have elevated levels of apolipoprotein B (apoB) and small dense LDL (lipoproteins).

 

Suspect familial combined hyperlipidaemia in a person with:
 - Moderate to severe mixed hyperlipidaemia (typically serum total cholesterol 6.5–8.0 mmol/l and serum triglycerides 2.3–5.0 mmol/l), and
 - Family history of hyperlipidaemia or premature CHD not due to familial hypercholesterolaemia”

 

With regard to testing it states:

 

“Familial hypercholesterolaemia is diagnosed in clinical practice, not by genetic testing, but by clinical features and standard laboratory tests of plasma cholesterol. This is because genetic tests are mainly used for research. Moreover genetic tests do not cover all cases of FH, as not all genetic causes of FH have been identified yet.

 

Familial hypercholesterolaemia is classified as

 

Definite if:
 - Total cholesterol concentration is greater than 7.5 mmol/l (either pre-treatment or highest on treatment) in adults over 16 years, or LDL cholesterol is greater than 4.9 mmol/l, and
 - Tendon xanthomata in the person or a first- or second-degree relative, and/or DNA-based evidence of an LDL-receptor mutation or familial defective apoB-100

 

Possible if:
 - Total cholesterol concentration is greater than 7.5 mmol/l (either pre-treatment or highest on treatment) in adults over 16 years, or LDL cholesterol is greater than 4.9 mmol/l, and
 - Family history of myocardial infarction before age 50 years in second-degree relative or before age 60 years in first-degree relative, or
 - Family history of raised total cholesterol is greater than 7.5 mmol/l in a first- or second-degree relative”

 

Reference

1) http://cks.library.nhs.uk/cardiovascular_risk/view_whole_guidance


DISCLAIMER: TRIPanswers is a collection of clinical questions and answers.  Each provider will have their own methodology in answering questions and these are likely not to be as rigorous as systematic review.  If you have any doubt as to the implications of this contact the Q&A Service Provider for further information. This document is presented for information purposes only. This document cannot and should not be used as a basis of diagnosis or choice of treatment, and is in no way intended to replace professional medical care or attention by a qualified practitioner. TRIPanswers and TRIP Database Ltd are not responsible or liable for, directly or indirectly, ANY form of damage whatsoever resulting from the use/misuse of information contained in or implied by this document.  Also, ensure you have read the terms and conditions for using the site.

Need to search for more evidence?

Help us improve this answer

Leave comments or suggestions below

Disclaimer:

TRIP will review each comment and will only publish those we feel will enhance a particular answer.  As a result of the review process there will be a delay between submission and publication of accepted comments.